Russell Frank Company’s NxStage Medical Inc. NXTM Stock Holding History

Russell Frank Company’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-32,067	Closed	-$717K	–	3090
2015 Q4	$717K	Sell	32,067 -1,806	-5%	-$33.7K	﹤0.01%	2353
2015 Q3	$534K	Buy	+33,873	New	+$543K	﹤0.01%	2452
2015 Q2	–	Sell	-29,937	Closed	-$518K	–	3125
2015 Q1	$518K	Buy	29,937 +11,355	+61%	+$201K	﹤0.01%	2399
2014 Q4	$333K	Buy	+18,582	New	+$299K	﹤0.01%	2495
2013 Q4	–	Sell	-318	Closed	-$4K	–	3214
2013 Q3	$4K	Buy	318 +8	+3%	+$105	﹤0.01%	3335
2013 Q2	$4K	Buy	+310	New	+$3.9K	﹤0.01%	3130

Other funds holding NXTM

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Russell Frank Company's NXTM Position: Q1 2016 in Review

Russell Frank Company sold out of NxStage Medical Inc. (NXTM) in Q1 2016, closing a stake of 32,067 shares — an estimated $717K sold.

Russell Frank Company first reported a position in NXTM in Q2 2013 and held it in 6 quarters. The position peaked at $717K in Q4 2015. 140 funds tracked by Wall St. Rank hold NXTM as of Q1 2016.

Russell Frank Company reported no remaining NxStage Medical Inc. position as of Q1 2016 after selling out during the quarter.
Russell Frank Company sold 32,067 NxStage Medical Inc. shares in Q1 2016, an estimated $717K.
Russell Frank Company first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 6 quarters.
Russell Frank Company's NxStage Medical Inc. position peaked at $717K in Q4 2015.
140 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.